1. Dr Jishanth M Prof Dr A Gowrisankar’s Unit, M4 2. Mr A SHANMUGAM, 28 yr/M, Unmarried, working in a shop, admitted on 27-11-2007 with inability to speak, motor weakness…

1. SPARCL TRIAL: HIGH-DOSE ATORVASTATIN AFTER STROKE OR TRANSIENT ISCHEMIC ATTACK PRESENTED BY: TING CHUONG WEI KENNY GOH WEI CHUAN CHEN SIAW MING 12-12-2007 2. Atherosclerosis…

1. Pharmacogenetics of Statin Therapies Daniel I. Chasman, Ph.D.Division of Preventive MedicineBrigham and Women’s HospitalJohanna and Ralph DeStefano Personalized Health…

1. Pharmacogenetics of Statin Therapies Daniel I. Chasman, Ph.D. Division of Preventive Medicine Brigham and Women’s Hospital Johanna and Ralph DeStefano Personalized Health…

1. BARIATRIC SURGERY: A PHARMACY PERSPECTIVEHassan Hammoud, PharmD Candidate 2012 Thomas Jefferson UniversityPreceptor: Sarah Nordbeck, PharmD, BCNSP Nutrition Support Services…

Microsoft Word - HolmbergKappaSlutversion21 April.docPrevention of risk factors page 1 UMEÅ UNIVERSITY MEDICAL DISSERTATIONS New series No 1574 - ISSN 0346-6612 - ISBN

Art. 1.1361processes, in addition to being capable of im- proving therapeutic compliance, appears to be reasonable. Statins, which are HMG-CoA reductase in- hibitors, are

Masadeh et al. Annals of Clinical Microbiology and Antimicrobials 2012, 11:13 http://www.ann-clinmicrob.com/content/11/1/13 RESEARCH Open Access Abstract Background: Statins

Impact of Atorvastatin on Skeletal Muscle Mitochondrial Activity, Locomotion and Axonal Excitability—Evidence from ApoE-/- MiceGreco, M.F.; Mozzo, M.; Melfi, V.; Sirtori,

Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapyREVIEW Actions of metformin and statins on lipid